株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

世界の妊婦用ビタミンサプリメント市場:2020年~2024年の予測

Global Prenatal Vitamin Supplements Market

発行 TechNavio (Infiniti Research Ltd.) 商品コード 359360
出版日 ページ情報 英文 120 Pages
即納可能
価格
本日の銀行送金レート: 1USD=113.11円で換算しております。
Back to Top
世界の妊婦用ビタミンサプリメント市場:2020年~2024年の予測 Global Prenatal Vitamin Supplements Market
出版日: 2020年02月13日 ページ情報: 英文 120 Pages
概要

世界の妊婦用ビタミンサプリメント市場は、予測期間中に8%のCAGRで成長する見通しで、2024年には1億9,569万米ドルに達すると予測されています。産婦人科医による妊婦へのビタミンサプリメント推奨の増加や、出生前のビタミンサプリメント製造企業による人工知能の使用などの要因は、同市場の成長を牽引している要因です。

当レポートは世界の妊婦用ビタミンサプリメント市場について調査しており、市場機会、動向や課題、成長要因、流通チャネル・地域別の市場分析、競合情勢、主要企業のプロファイル等の情報を提供しています。

目次

エグゼクティブサマリー

  • 市場概況

市場の風景

  • 市場エコシステム
  • バリューチェーン分析

市場規模

  • 市場の定義
  • 市場セグメント分析
  • 市場規模:2019年
  • 市場の見通し:2019-2024年の予測

ポーターのファイブフォース分析

  • ファイブフォースサマリー
  • 市況

市場分析:流通チャネル別

  • 市場セグメンテーション
  • 比較
  • 従来の小売
  • 直接販売・eリテイリング
  • 市場機会

顧客の風景

  • 概要

市場分析:地域別

  • 市場セグメンテーション
  • 比較
  • 北米
  • 欧州
  • アジア太平洋地域
  • 南米
  • 中東・アフリカ
  • 主要国
  • 市場機会

市場成長要因、課題、および動向

  • 市場成長要因
  • 取引量成長要因:需要主導の成長
  • 取引量成長要因:供給主導の成長
  • 取引量成長要因:外部要因
  • 取引量成長要因:関連市場での需要の移行
  • 価格成長要因:インフレ
  • 価格成長要因:低価格から高価格への移行
  • 市場の課題
  • 市場動向

ベンダー情勢

  • 概要
  • ベンダー情勢
  • 情勢の革新

ベンダー分析

  • 対象ベンダー
  • ベンダーの市場での位置づけ
  • Abbott Laboratories
  • Atrium Innovations Inc.
  • Bayer AG
  • Church & Dwight Co. Inc.
  • FoodState Inc.
  • Nordic Naturals
  • Nutranext
  • 大塚ホールディングス株式会社
  • The Procter & Gamble Co.
  • TherapeuticsMD Inc.

付録

  • レポートの範囲
  • 米ドルの為替レート
  • 調査方法
  • 略語のリスト
目次
Product Code: IRTNTR41009

Technavio has been monitoring the global prenatal vitamin supplements market and it is poised to grow by USD 195.69 mn during 2020-2024, progressing at a CAGR of 8% during the forecast period. Our reports on global prenatal vitamin supplements market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by increasing number of gynecologists recommending prenatal vitamin supplements to expecting mothers.

In addition, usage of artificial intelligence by prenatal vitamin supplement manufacturing players is anticipated to boost the growth of the global prenatal vitamin supplements market as well.

Market Segmentation

Technavioa's global prenatal vitamin supplements market is segmented as below:

  • Distribution channel
  • Conventional retail channels
  • Direct selling and e-retailing

Geographic segmentation

  • North America
  • APAC
  • Europe
  • South America
  • MEA

Key Trends for global prenatal vitamin supplements market growth

This study identifies usage of artificial intelligence by prenatal vitamin supplement manufacturing players as the prime reasons driving the global prenatal vitamin supplements market growth during the next few years.

Prominent vendors in global prenatal vitamin supplements market

We provide a detailed analysis of around 25 vendors operating in the global prenatal vitamin supplements market, including some of the vendors such as Abbott Laboratories, Atrium Innovations Inc., Bayer AG, Church & Dwight Co. Inc., FoodState Inc., Nordic Naturals, Nutranext, Otsuka Holdings Co. Ltd., The Procter & Gamble Co. and TherapeuticsMD Inc. .

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. Technavioa's market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast an accurate market growth.

Table of Contents

Executive Summary

  • Market Overview

Market Landscape

  • Market ecosystem
  • Value chain analysis

Market Sizing

  • Market definition
  • Market segment analysis
  • Market size 2019
  • Market outlook: Forecast for 2019 - 2024

Five Forces Analysis

  • Five Forces Summary
  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition

Market Segmentation by Distribution channel

  • Market segments
  • Comparison by Distribution channel placement
  • Conventional retail channels - Market size and forecast 2019-2024
  • Direct selling and e-retailing - Market size and forecast 2019-2024
  • Market opportunity by Distribution channel

Customer landscape

  • Overview

Geographic Landscape

  • Geographic segmentation
  • Geographic comparison
  • North America - Market size and forecast 2019-2024
  • Europe - Market size and forecast 2019-2024
  • APAC - Market size and forecast 2019-2024
  • South America - Market size and forecast 2019-2024
  • MEA - Market size and forecast 2019-2024
  • Key leading countries
  • Market opportunity by geography

Drivers, Challenges, and Trends

  • Market drivers
  • Volume driver - Demand led growth
  • Volume driver - Supply led growth
  • Volume driver - External factors
  • Volume driver - Demand shift in adjacent markets
  • Price driver - Inflation
  • Price driver - Shift from lower to higher priced units
  • Market challenges
  • Market trends

Vendor Landscape

  • Overview
  • Vendor landscape
  • Landscape disruption

Vendor Analysis

  • Vendors covered
  • Market positioning of vendors
  • Abbott Laboratories
  • Atrium Innovations Inc.
  • Bayer AG
  • Church & Dwight Co. Inc.
  • FoodState Inc.
  • Nordic Naturals
  • Nutranext
  • Otsuka Holdings Co. Ltd.
  • The Procter & Gamble Co.
  • TherapeuticsMD Inc.

Appendix

  • Scope of the report
  • Currency conversion rates for US$
  • Research methodology
  • List of abbreviations

List of Exhibits:

  • 1.Key Finding 1
  • 2.Key Finding 2
  • 3.Key Finding 3
  • 4.Key Finding 4
  • 5.Key Finding 5
  • 6.Key Finding 6
  • 7.Key Finding 7
  • 8.Market in focus
  • 9.Parent market
  • 10.Market characteristics
  • 11.Product / Service portfolio of key vendors included in the market definition
  • 12.Market segments
  • 13.Global - Market size and forecast 2019 - 2024 ($ million)
  • 14.Global market: Year-over-year growth 2019 - 2024 (%)
  • 15.Five forces analysis 2019 & 2024
  • 16.Bargaining power of buyers
  • 17.Bargaining power of suppliers
  • 18.Threat of new entrants
  • 19.Threat of substitutes
  • 20.Threat of rivalry
  • 21.Market condition - Five forces 2019
  • 22.Distribution channel placement - Market share 2019-2024 (%)
  • 23.Comparison by Distribution channel placement
  • 24.Conventional retail channels - Market size and forecast 2019-2024 ($ million)
  • 25.Conventional retail channels - Year-over-year growth 2019-2024 (%)
  • 26.Direct selling and e-retailing - Market size and forecast 2019-2024 ($ million)
  • 27.Direct selling and e-retailing - Year-over-year growth 2019-2024 (%)
  • 28. Market opportunity by Distribution channel
  • 29.Customer landscape
  • 30.Market share by geography 2019-2024 (%)
  • 31.Geographic comparison
  • 32.North America - Market size and forecast 2019-2024 ($ million)
  • 33.North America - Year-over-year growth 2019-2024 (%)
  • 34.Europe - Market size and forecast 2019-2024 ($ million)
  • 35.Europe - Year-over-year growth 2019-2024 (%)
  • 36.APAC - Market size and forecast 2019-2024 ($ million)
  • 37.APAC - Year-over-year growth 2019-2024 (%)
  • 38.South America - Market size and forecast 2019-2024 ($ million)
  • 39.South America - Year-over-year growth 2019-2024 (%)
  • 40.MEA - Market size and forecast 2019-2024 ($ million)
  • 41.MEA - Year-over-year growth 2019-2024 (%)
  • 42.Key leading countries
  • 43.Market opportunity by geography ($ million)
  • 44.Impact of drivers
  • 45.Impact of challenges
  • 46.Landscape disruption
  • 47.Industry risks
  • 48.Vendors covered
  • 49.Market positioning of vendors
  • 50.Abbott Laboratories - Overview (1/3)
  • 51.Abbott Laboratories - Overview (2/3)
  • 52.Abbott Laboratories - Overview (3/3)
  • 53.Abbott Laboratories - Business segments
  • 54.Abbott Laboratories - Key offerings
  • 55.Abbott Laboratories - Key customers
  • 56.Abbott Laboratories - Segment focus
  • 57.Atrium Innovations Inc. - Overview (1/3)
  • 58.Atrium Innovations Inc. - Overview (2/3)
  • 59.Atrium Innovations Inc. - Overview (3/3)
  • 60.Atrium Innovations Inc. - Business segments
  • 61.Atrium Innovations Inc. - Key offerings
  • 62.Atrium Innovations Inc. - Key customers
  • 63.Atrium Innovations Inc. - Segment focus
  • 64.Bayer AG - Overview (1/3)
  • 65.Bayer AG - Overview (2/3)
  • 66.Bayer AG - Overview (3/3)
  • 67.Bayer AG - Business segments
  • 68.Bayer AG - Key offerings
  • 69.Bayer AG - Key customers
  • 70.Bayer AG - Segment focus
  • 71.Church & Dwight Co. Inc. - Overview (1/3)
  • 72.Church & Dwight Co. Inc. - Overview (2/3)
  • 73.Church & Dwight Co. Inc. - Overview (3/3)
  • 74.Church & Dwight Co. Inc. - Business segments
  • 75.Church & Dwight Co. Inc. - Key offerings
  • 76.Church & Dwight Co. Inc. - Key customers
  • 77.Church & Dwight Co. Inc. - Segment focus
  • 78.FoodState Inc. - Overview (1/3)
  • 79.FoodState Inc. - Overview (2/3)
  • 80.FoodState Inc. - Overview (3/3)
  • 81.FoodState Inc. - Product and service
  • 82.FoodState Inc. - Key offerings
  • 83.FoodState Inc. - Key customers
  • 84.FoodState Inc. - Segment focus
  • 85.Nordic Naturals - Overview (1/3)
  • 86.Nordic Naturals - Overview (2/3)
  • 87.Nordic Naturals - Overview (3/3)
  • 88.Nordic Naturals - Business segments
  • 89.Nordic Naturals - Key offerings
  • 90.Nordic Naturals - Key customers
  • 91.Nordic Naturals - Segment focus
  • 92.Nutranext - Overview (1/3)
  • 93.Nutranext - Overview (2/3)
  • 94.Nutranext - Overview (3/3)
  • 95.Nutranext - Business segments
  • 96.Nutranext - Key offerings
  • 97.Nutranext - Key customers
  • 98.Nutranext - Segment focus
  • 99.Otsuka Holdings Co. Ltd. - Overview (1/3)
  • 100.Otsuka Holdings Co. Ltd. - Overview (2/3)
  • 101.Otsuka Holdings Co. Ltd. - Overview (3/3)
  • 102.Otsuka Holdings Co. Ltd. - Business segments
  • 103.Otsuka Holdings Co. Ltd. - Key offerings
  • 104.Otsuka Holdings Co. Ltd. - Key customers
  • 105.Otsuka Holdings Co. Ltd. - Segment focus
  • 106.The Procter & Gamble Co. - Overview (1/3)
  • 107.The Procter & Gamble Co. - Overview (2/3)
  • 108.The Procter & Gamble Co. - Overview (3/3)
  • 109.The Procter & Gamble Co. - Business segments
  • 110.The Procter & Gamble Co. - Key offerings
  • 111.The Procter & Gamble Co. - Key customers
  • 112.The Procter & Gamble Co. - Segment focus
  • 113.TherapeuticsMD Inc. - Overview (1/3)
  • 114.TherapeuticsMD Inc. - Overview (2/3)
  • 115.TherapeuticsMD Inc. - Overview (3/3)
  • 116.TherapeuticsMD Inc. - Business segments
  • 117.TherapeuticsMD Inc. - Key offerings
  • 118.TherapeuticsMD Inc. - Key customers
  • 119.TherapeuticsMD Inc. - Segment focus
  • 120.Currency conversion rates for US$
  • 121.Research Methodology
  • 122.Validation techniques employed for market sizing
  • 123.Information sources
  • 124.List of abbreviations
Back to Top